OncoSec Medical Incorporated
ONCS
ONCS was delisted on the 23rd of June, 2023.
26 hedge funds and large institutions have $7.47M invested in OncoSec Medical Incorporated in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 0 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
62% more capital invested
Capital invested by funds: $4.6M → $7.47M (+$2.87M)
44% more funds holding
Funds holding: 18 → 26 (+8)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$3.02M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$96.3K |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$64.7K |
| 4 |
SIM
Spark Investment Management
New York
|
+$43.6K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$40.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$752 |
ONCS Hedge Fund Activity: Q4 2015 in Review
26 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in OncoSec Medical Incorporated (ONCS) for Q4 2015, worth a combined $7.47M — up 62% from $4.6M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new ONCS positions and 0 closed out — a net gain of 8 holders — while 6 added to existing stakes and 1 trimmed.
The largest buyer was Sabby Management, adding an estimated $3.02M. The largest seller was Morgan Stanley, cutting an estimated $752.
- 26 institutional investors held OncoSec Medical Incorporated (ONCS) as of Q4 2015, up from 18 in Q3 2015.
- Funds reported $7.47M of OncoSec Medical Incorporated stock for Q4 2015, up 62% quarter-over-quarter.
- 8 funds opened new OncoSec Medical Incorporated positions in Q4 2015 and 0 closed out, a net change of +8 holders.
- The largest OncoSec Medical Incorporated buyer in Q4 2015 was Sabby Management, an estimated $3.02M added.
- The largest OncoSec Medical Incorporated seller in Q4 2015 was Morgan Stanley, an estimated $752 sold.
Based on aggregated 13F filings for Q4 2015.